Polyisoprenylated Benzophenone, Garcinol, a Natural Histone Acetyltransferase Inhibitor, Represses Chromatin Transcription and Alters Global Gene Expression*
暂无分享,去创建一个
T. Kundu | V. Swaminathan | Radhika A. Varier | Parag P Sadhale | Karanam Balasubramanyam | Tapas K Kundu | M Altaf | Radhika A Varier | V Swaminathan | Aarti Ravindran | P. Sadhale | M. Altaf | K. Balasubramanyam | Aarti Ravindran
[1] Jun Qin,et al. Histone-like TAFs within the PCAF Histone Acetylase Complex , 1998, Cell.
[2] P. Cole,et al. Transcriptional Coactivator Protein p300 , 2001, The Journal of Biological Chemistry.
[3] H. Nakazawa,et al. Free radical scavenging activity and antiulcer activity of garcinol from Garcinia indica fruit rind. , 2000, Journal of agricultural and food chemistry.
[4] Jen-kun Lin,et al. Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. , 2001, Journal of agricultural and food chemistry.
[5] Y. Nakatani,et al. The PCAF acetylase complex as a potential tumor suppressor. , 2000, Biochimica et biophysica acta.
[6] Sube Banerjee,et al. Histone acetylation-mediated regulation of genes in leukaemic cells , 2003 .
[7] K. Jeang,et al. Differential acetylation of Tat coordinates its interaction with the co‐activators cyclin T1 and PCAF , 2002, The EMBO journal.
[8] Tetsuro Ito,et al. Cytotoxic benzophenone derivatives from Garcinia species display a strong apoptosis-inducing effect against human leukemia cell lines. , 2003, Biological & pharmaceutical bulletin.
[9] Chihiro Ito,et al. Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities. , 2003, Journal of natural products.
[10] P. Cole,et al. Synthesis and analysis of potential prodrugs of coenzyme A analogues for the inhibition of the histone acetyltransferase p300. , 2003, Bioorganic & medicinal chemistry.
[11] S. Berger,et al. Histone modifications in transcriptional regulation. , 2002, Current opinion in genetics & development.
[12] N. Shiama. The p300/CBP family: integrating signals with transcription factors and chromatin. , 1997, Trends in cell biology.
[13] D. Sterner,et al. Acetylation of Histones and Transcription-Related Factors , 2000, Microbiology and Molecular Biology Reviews.
[14] P. Marks,et al. Histone deacetylases and cancer: causes and therapies , 2001, Nature Reviews Cancer.
[15] R. Roeder,et al. Human TFIIIC Relieves Chromatin-Mediated Repression of RNA Polymerase III Transcription and Contains an Intrinsic Histone Acetyltransferase Activity , 1999, Molecular and Cellular Biology.
[16] J. Loeffler,et al. Critical loss of CBP/p300 histone acetylase activity by caspase‐6 during neurodegeneration , 2003, The EMBO journal.
[17] Tiziana Bonaldi,et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.
[18] B. Hamkalo,et al. Chromatin Structure and Function , 1979, NATO Advanced Study Institutes Series.
[19] K. Ozato,et al. Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] L. Kedes,et al. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. , 1997, Molecular cell.
[21] B. Howard,et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.
[22] V. Kiermer,et al. Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. , 2003, Molecular cell.
[23] C. Allis,et al. Steroid receptor coactivator-1 is a histone acetyltransferase , 1997, Nature.
[24] R. Hennekam,et al. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. , 2003, Human molecular genetics.
[25] Ben Berkhout,et al. Synergistic Activation of Human Immunodeficiency Virus Type 1 Promoter Activity by NF-κB and Inhibitors of Deacetylases: Potential Perspectives for the Development of Therapeutic Strategies , 2002, Journal of Virology.
[26] Claudio Nicolini,et al. Chromatin Structure and Function , 1979, NATO Advanced Study Institutes Series.
[27] W. Shaiu,et al. Targeting to Transcriptionally Active Loci by the Hydrophilic N-Terminal Domain of Drosophila DNA Topoisomerase I , 1998, Molecular and Cellular Biology.
[28] R. Roeder,et al. Selective requirements for histone H3 and H4 N termini in p300-dependent transcriptional activation from chromatin. , 2002, Molecular cell.
[29] R. Roeder,et al. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. , 2000, Molecular cell.
[30] A. Harel-Bellan,et al. CBP/p300 and muscle differentiation: no HAT, no muscle , 2001, The EMBO journal.
[31] R. Evans,et al. Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase , 1999, Cell.
[32] Tapas K. Kundu,et al. Small Molecule Modulators of Histone Acetyltransferase p300* , 2003, Journal of Biological Chemistry.
[33] T. Kundu,et al. p300-mediated Acetylation of Human Transcriptional Coactivator PC4 Is Inhibited by Phosphorylation* , 2001, The Journal of Biological Chemistry.
[34] C. Disteche,et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein , 1996, Nature Genetics.
[35] W. Bonner,et al. Two-dimensional gel analysis of histones in acid extracts of nuclei, cells, and tissues. , 1980, European journal of biochemistry.
[36] M. Giacca,et al. Regulation of HIV‐1 gene expression by histone acetylation and factor recruitment at the LTR promoter , 2003, The EMBO journal.
[37] B. Alberts,et al. Inhibition of histone acetylation by N-[2-(S-coenzyme A)acetyl] spermidine amide, a multisubstrate analog. , 1982, The Journal of biological chemistry.
[38] G. Blobel,et al. CREB-Binding Protein Acetylates Hematopoietic Transcription Factor GATA-1 at Functionally Important Sites , 1999, Molecular and Cellular Biology.
[39] C. Glass,et al. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. , 2001, Human molecular genetics.
[40] P. Marks,et al. Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers. , 2001, Blood cells, molecules & diseases.
[41] Z. Wang,et al. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. , 2000, Molecular cell.
[42] A. Wolffe,et al. Chromatin remodeling: why it is important in cancer , 2001, Oncogene.